Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 646,000 | 340,500 | 1,521,900 | 1,123,500 | 780,000 |
| Depreciation Amortization | 71,300 | 35,200 | 139,600 | 104,200 | 68,800 |
| Income taxes - deferred | -134,700 | -51,800 | -254,500 | -148,700 | -102,400 |
| Accounts receivable | -124,300 | -77,500 | -84,100 | -83,000 | -77,700 |
| Other Working Capital | -283,500 | -85,900 | -421,400 | -300,400 | -202,300 |
| Other Operating Activity | 172,900 | 153,600 | 316,700 | 239,800 | 159,100 |
| Operating Cash Flow | $347,700 | $314,100 | $1,218,200 | $935,400 | $625,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -109,400 | -61,500 | -244,600 | -175,700 | -115,800 |
| Net Acquisitions | -156,200 | -156,200 | -109,600 | -107,600 | -55,500 |
| Purchase Of Investment | -22,300 | -15,700 | -669,300 | -588,300 | -295,000 |
| Sale Of Investment | 398,000 | 263,900 | 1,359,100 | 1,085,600 | 861,600 |
| Purchase Sale Intangibles | -13,300 | -13,100 | -20,200 | N/A | N/A |
| Other Investing Activity | -39,400 | -30,000 | -83,300 | -56,400 | -36,200 |
| Investing Cash Flow | $70,700 | $500 | $252,300 | $157,600 | $359,100 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 102,700 | 41,900 | 146,400 | 118,900 | 86,500 |
| Common Stock Repurchased | -256,800 | -249,300 | -1,727,100 | -861,100 | -760,700 |
| Other Financing Activity | -400 | 800 | -3,800 | -3,900 | -2,000 |
| Financing Cash Flow | $-154,500 | $-206,600 | $-1,584,500 | $-746,100 | $-676,200 |
| Exchange Rate Effect | 11,000 | -4,200 | 19,200 | 37,400 | 27,100 |
| Beginning Cash Position | 772,600 | 772,600 | 867,400 | 867,400 | 867,400 |
| End Cash Position | 1,047,500 | 876,400 | 772,600 | 1,251,700 | 1,202,900 |
| Net Cash Flow | $274,900 | $103,800 | $-94,800 | $384,300 | $335,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 347,700 | 314,100 | 1,218,200 | 935,400 | 625,500 |
| Capital Expenditure | -109,400 | -61,500 | -244,600 | -175,700 | -115,800 |
| Free Cash Flow | 238,300 | 252,600 | 973,600 | 759,700 | 509,700 |